US Patent Issued to CALLIDITAS THERAPEUTICS SUISSE on May 5 for "Pyrazolo pyridine derivatives as NADPH oxidase inhibitors" (French, British, Swiss Inventors)

ALEXANDRIA, Va., May 5 -- United States Patent no. RE50,878, issued on May 5, was assigned to CALLIDITAS THERAPEUTICS SUISSE SA (Plan-les-Ouales, Switzerland).

"Pyrazolo pyridine derivatives as NADPH oxidase inhibitors" was invented by Patrick Page (Saint-Julien-en-Genevois, France), Mike Orchard (Oxon, Great Britain), Benoit Laleu (Collonges-sous-Saleve, France) and Francesca Gaggini (Geneva).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidas...